Business Wire

United States, China, and United Kingdom Lead the Global AI Ranking According to Stanford HAI’s Global AI Vibrancy Tool

21.11.2024 15:00:00 EET | Business Wire | Press release

Share

The Stanford Institute for Human-Centered AI (HAI) AI Index today released its Global AI Vibrancy Tool which allows flexible comparisons of 36 countries based on 42 openly available AI-specific indicators. Comparisons between countries can be made using either absolute or per capita versions of the indicators and are supported by interactive visualizations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241121006002/en/

Graphic: Stanford Institute for Human-Centered Artificial Intelligence (HAI)

The Global AI Vibrancy Tool measures the strength of the AI ecosystems based on 8 pillars — research and development, responsible AI, economy, education, diversity, policy and governance, public opinion, and infrastructure — with indicators including AI journal publications, total AI private investment, AI legislation passed, and foundation model datasets.

It is designed to empower policymakers, industry leaders, researchers, and the public with actionable, data-driven insights into national AI development that allows audiences to explore the findings in a way that’s most relevant to their goals. Policymakers can use the tool to strategically guide policy decisions, enterprises can gain insights into global AI market trends, and the general public can access concrete data to better understand the evolving debates around AI.

The Global AI Vibrancy Tool is available now at https://aiindex.stanford.edu/vibrancy/. The Stanford HAI AI Index hopes to further encourage global stakeholders to improve their data collection and sharing efforts in the interest of improving visibility into the global AI ecosystem. Regular updates will ensure the tool remains a valuable resource for tracking global AI development.

Using a set of weights determined by a panel of experts, this year’s top ten countries are as follows:

  1. United States: the U.S. leads the ranking by a significant margin and excels in the research and development (R&D) and in the AI economy pillars. The U.S. consistently produces the most notable AI machine learning models, attracts the highest levels of private AI investment, and leads in publishing responsible AI research.
  2. China: China demonstrates substantial strengths in the R&D, economy, and infrastructure pillars. China's focus on developing cutting-edge AI technologies and increasing its R&D investments has positioned it as a major AI powerhouse.
  3. United Kingdom: the U.K. demonstrates particular strength in the R&D, education, and policy and governance pillars.
  4. India: India has strong performance in R&D and recent improvements in the economy pillar.
  5. The United Arab Emirates: The U.A.E. scores highly on the economy pillar.
  6. France: France ranks sixth and shows strength in the policy and governance, education, and infrastructure pillars.
  7. South Korea: South Korea ranks seventh, scoring highly in the policy and governance, infrastructure, and public opinion pillars.
  8. Germany: Germany ranks eight, showing strength in the R&D, responsible AI, and education pillars.
  9. Japan: Japan demonstrates strong performance in the infrastructure, R&D, and economy pillars.
  10. Singapore: Singapore shows strength in the economy, diversity, and responsible AI pillars.

“AI has increased as a topic of national interest, and correspondingly narratives about which countries lead in AI have become more prominent than ever,” said Nestor Maslej, Project Manager of the AI Index. “However, there’s limited data providing a clear, quantitative view of where countries actually stand in AI. At the Index, we wanted to address this gap with a rigorous tool that could help policymakers, business leaders, and the public ground these geopolitical AI narratives in fact.”

About the AI Index

The AI Index report tracks, collates, distills, and visualizes data related to artificial intelligence (AI). Our mission is to provide unbiased, rigorously vetted, broadly sourced data in order for policymakers, researchers, executives, journalists, and the general public to develop a more thorough and nuanced understanding of the complex field of AI. The AI Index is recognized globally as one of the most credible and authoritative sources for data and insights on artificial intelligence.

About the Stanford Institute for Human-Centered AI (HAI)

The Stanford Institute for Human-Centered AI (HAI) is an interdisciplinary institute established in 2019 to advance AI research, education, policy, and practice. Stanford HAI brings together thought leaders from academia, industry, government, and civil society to shape the development and responsible deployment of AI. Stanford HAI’s mission is to advance AI research, education, policy, and practice to improve the human condition. We believe AI should be guided by its human impact, inspired by human intelligence, and designed to augment, not replace, people. Our interdisciplinary faculty conducts research focused on guiding the development of AI technologies intended to enhance human capabilities while ensuring its ethical, fair, and transparent use.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241121006002/en/

Contacts

stanfordhai@signalgroup.co

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye